Next trading week will be short, but these high-potential picks will help ensure it’s mighty:
-
Jazz Pharmaceuticals (JAZZ) gains momentum amid pipeline advances
-
Flowserve (FLS) sets the stage for clean growth ahead
-
Micron Technology (MU): Better than NVDA?
-
Ciena (CIEN) emerges as a prime AI pick
-
Tapestry (TPR) is picking up speed (again!)
P.S. Miss last week's picks? Get them here.
A note from our sponsors...
10 Best Stocks to Own in 2026
Enter your email address below and we'll send you MarketBeat's list of the 10 best stocks to own in 2026 and why they should be in your portfolio. You will also receive our free daily email newsletter with the latest buy and sell recommendations from Wall Street's top analysts.
Get your copy now here
1- Tapestry (NYSE: TPR)
Tapestry is up 56% since its addition to the Zen Investor portfolio … The move may not be over. The stock’s gaining serious momentum as Coach’s North America sales surge, driving market-share wins and upbeat estimate revisions heading into the key holiday season.
Zen Rating: Buy (B) — see full analysis
Recent Price: $124.56 — get current quote
Max 1-year forecast: $148.00
Why we're watching:
- Analyst support: TPR commands impressive Wall Street backing with 8 Strong Buy, 4 Buy, and only 2 Hold ratings among the 14 analysts we track covering the luxury retailer. See the ratings
- JP Morgan's Matthew Boss (top 9%) maintains a Strong Buy rating with the Street-high $148 price target, representing 20% upside potential from current levels.
- Wells Fargo analyst Ike Boruchow (top 6%) maintained his Strong Buy rating with a $125 price target following the company's strong operational performance.
- Industry ranking context: TPR is currently the 4th highest-rated stock in the Luxury industry, which has an Industry Rating of A.
- Zen Rating highlights: Buy (B) stocks are no slouch — they have historically averaged +19.88%/yr — TPR showcases exceptional profitability with return on equity of 361%, far exceeding both its industry and the broader market averages.
- Component Grades: The company earns an A grade in Financials with a 16.1% profit margin, demonstrating strong operational efficiency and pricing power in the competitive luxury market. See all 7 Zen Component Grades here
Ciena Corporation just delivered a blowout Q4 and is emerging as a prime beneficiary of AI-driven network upgrades, with analysts piling in behind its accelerating momentum.
Zen Rating: Strong Buy (A) — see full analysis
Recent Price: $214.37 — get current quote
Max 1-year forecast: $305.00
Why we're watching:
- Analyst support: Right now, CIEN enjoys 7 Strong Buy, 1 Buy, and 4 Hold ratings among the analysts we track covering the stock. See the ratings
- Citigroup analyst Atif Malik (a top 1% rated analyst) recently maintained his Strong Buy rating with a $280 price target following robust earnings. The analyst cited strong fundamentals and attractive valuation which justifies the rating, highlighting strong demand for products and market expansion opportunities.
- Industry ranking context: CIEN is currently the 8th highest-rated stock out of 49 in the Communication Equipment industry, which has an Industry Rating of B.
- Zen Rating highlights: With its Strong Buy (A) rating, CIEN is in a class of stocks that have historically trounced the S&P with +32.52% average annual returns. CIEN demonstrates exceptional growth potential with earnings forecast to surge 193% over the next year as AI infrastructure investments accelerate.
- Component Grades: The stock earns top marks with an A grade in both Growth and Artificial Intelligence components, reflecting its strategic positioning in high-growth technology sectors. See all 7 Zen Component Grades here
A note from our sponsors...
What's Nvidia's Dirty Secret?
Nvidia's charging into two seismic tech frontiers projected to be worth over $24 TRILLION!
And they're in a race to dominate first. But here's the dirty secret Nvidia won't admit...
They can't do it alone. Nvidia needs 3 Silent Partners... This $24 trillion pivot hinges on them.
Click here now and find out about 3 companies critical to Nvidia's success in 2026.
3- Micron Technology Inc (NASDAQ: MU)
Our latest Stock of the Week is heading into Q1 earnings with powerful momentum, as surging AI-driven demand for high-bandwidth memory signals a fresh upcycle in the chip industry.
Zen Rating: Strong Buy (A) — see full analysis
Recent Price: $245.75 — get current quote
Max 1-year forecast: $338.00
Why we're watching:
- Analyst support: The memory leader commands exceptional Wall Street conviction among the analysts we track. It has 16 Strong Buy, 8 Buy, and only 2 Hold ratings among 26 analysts covering the stock. See the ratings
- For example, Stifel Nicolaus analyst Brian Chin (top 5%) recently maintained a Strong Buy rating with a $300 price target, representing 24% upside potential from current levels.
- According to Zen Investor Editor in Chief Steve Reitmeister, who recently spotlighted MU as his Stock of the Week, Micron (MU) offers leveraged exposure to the AI boom at a far cheaper valuation than Nvidia, with explosive earnings growth expected and a fraction of NVDA’s multiple.
- Industry ranking context: MU ranks #1 in the Semiconductor industry, which has an Industry Rating of C.
- Zen Rating highlights: MU earns the highest Zen Rating possible — A (Strong Buy). Stocks in this tier have historically delivered 32.52% annual returns.
- Component Grades: The stock earns strong marks across key factors including an A grade in Momentum, B grades in Value, Growth, and Safety, positioning it as a balanced high-quality semiconductor play. See all 7 Zen Component Grades here
4- Flowserve Corp (NYSE: FLS)
Flowserve just cleared two major overhangs—acquiring Greenray Turbine Solutions and exiting legacy asbestos liabilities—setting the stage for faster, cleaner growth ahead.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $69.20 — get current quote
Max 1-year forecast: $85.00
Why we're watching:
- Analyst support: Flowserve enjoys robust analyst backing with 5 Strong Buy, 1 Buy, and 2 Hold ratings among 8 analysts we track providing coverage. See the ratings
- For example, Citigroup's Andy Kaplowitz (a top 1% rated analyst) recently maintained a Strong Buy rating with an $82 price target, citing a bullish long-term view supported by strong fundamentals and strategic initiatives with market adaptability.
- Stifel Nicolaus analyst Nathan Jones (top 2%) maintained a Strong Buy rating with a $66 price target, though cautious about uncertain market conditions while monitoring volatile factors that could impact forecasts.
- Industry ranking context: Flowserve is currently the 2nd highest-rated stock of 70 companies in the Specialty Industrial Machinery industry, which has an Industry Rating of A.
- Zen Rating highlights: FLS is an A-rated (Strong Buy) stock, meaning it’s in the top 5% of the 4600+ tickers we track based on a rigorous review of 115 factors proven to drive stock growth.
- Component Grades: Flowserve demonstrates solid fundamentals with a B in Value, B in Sentiment, B in Safety, B in Financials, balanced by a C in Growth and C in Momentum. See all 7 Zen Component Grades here
5- Jazz Pharmaceuticals (NASDAQ: JAZZ)
Jazz Pharmaceuticals is gaining momentum as key pipeline advances and upcoming pivotal data for its cancer therapy Ziihera put the company on the cusp of a major oncology growth phase.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $168.94 — get current quote
Max 1-year forecast: $247.00
Why we're watching:
- Analysts love it: Right now, JAZZ enjoys 7 Strong Buy, 3 Buy, and just 1 Hold among the 11 analysts we follow covering the stock. See the ratings
- For example, JP Morgan's Jessica Fye (a top 4% rated analyst) recently maintained her Strong Buy rating with a $199 price target, noting that Jazz's strong fundamentals remain a compelling reason to invest with a focus on delivering shareholder value.
- Piper Sandler's David Amsellem (top 5%) recently reiterated his Strong Buy rating with a $219 price target, continuing to remain bullish on Jazz's growth potential due to its solid pipeline and strategic acquisitions.
-
Zen Rating highlights: Despite being in an iffy industry (Biotechs are volatile, y’all), JAZZ earns the highest Zen Rating possible — A (Strong Buy). Stocks in this tier have historically delivered 32.52% annual returns.
- Component Grades: Jazz earns high marks with an A in Value, B in Growth, B in Momentum, B in Safety, B in Financials, and B in AI components, demonstrating balanced strength across multiple dimensions. See all 7 Zen Component Grades here
What to Do Next?